Intuitive Surgical to report Q2 result amid persistent COVID-19 headwinds
Intuitive Surgical (NASDAQ:ISRG) is scheduled to announce Q2 earnings results on Thursday, July 21st, after market close.
The consensus EPS Estimate is $1.20 (-69.4% Y/Y) and the consensus Revenue Estimate is $1.56B (+6.8% Y/Y).
Over the last 2 years, ISRG has beaten EPS estimates 100% of the time and has beaten revenue estimates 100% of the time.

Over the last 3 months, EPS estimates have seen 2 upward revisions and 13 downward. Revenue estimates have seen 4 upward revisions and 10 downward.

The company's reported Q1 beat last quarter, helped by recovery in demand for its da Vinci Surgical Systems.
Last quarter, instruments and accessories revenue increased by 15% Y/Y to $810 million, primarily driven by about 19% growth in da Vinci procedure volume.
The company in April had said COVID-19 has had, and will likely continue to have, an adverse impact on the Companyâs procedure volumes. Shares of the company fell in April.
ISRG raised its 2022 forecast for procedure growth to 12%-16% from 11%-15%, the low end of the range assumes ongoing COVID and staffing pressure at hospitals and assumes some continued choppiness with COVID throughout the year.
Also read - Intuitive Surgical: Too Cheap For Robotic Surgery Leader